Cell	O
cycle-dependent	O
initiation	O
and	O
lineage-dependent	O
abrogation	O
of	O
GATA-1	B-protein
expression	O
in	O
pure	B-cell_type
differentiating	I-cell_type
hematopoietic	I-cell_type
progenitors	I-cell_type
.	O

The	O
programmed	O
activation/repression	O
of	O
transcription	B-protein
factors	I-protein
in	O
early	O
hematopoietic	O
differentiation	O
has	O
not	O
yet	O
been	O
explored	O
.	O

The	O
DNA-binding	B-protein
protein	I-protein
GATA-1	B-protein
is	O
required	O
for	O
normal	O
erythroid	O
development	O
and	O
regulates	O
erythroid-expressed	B-DNA
genes	I-DNA
in	O
maturing	B-cell_type
erythroblasts	I-cell_type
.	O

We	O
analyzed	O
GATA-1	B-protein
expression	O
in	O
early	O
human	O
adult	O
hematopoiesis	O
by	O
using	O
an	O
in	O
vitro	O
system	O
in	O
which	O
``	O
pure	O
''	O
early	B-cell_type
hematopoietic	I-cell_type
progenitors	I-cell_type
are	O
induced	O
to	O
gradual	O
and	O
synchronized	O
differentiation	O
selectively	O
along	O
the	O
erythroid	O
or	O
granulocyte-macrophage	O
pathway	O
by	O
differential	O
treatment	O
with	O
hematopoietic	O
growth	O
factors	O
.	O

The	O
GATA-1	B-DNA
gene	I-DNA
,	O
though	O
virtually	O
silent	O
in	O
quiescent	B-cell_type
progenitors	I-cell_type
,	O
is	O
activated	O
after	O
entrance	O
into	O
the	O
cell	O
cycle	O
upon	O
stimulation	O
with	O
hematopoietic	O
growth	O
factors	O
.	O

Subsequently	O
,	O
increasing	O
expression	O
along	O
the	O
erythroid	O
pathway	O
contrasts	O
with	O
an	O
abrupt	O
downregulation	O
in	O
the	O
granulocyte-macrophage	B-cell_type
lineage	I-cell_type
.	O

These	O
results	O
suggest	O
a	O
microenvironment-directed	O
,	O
two-step	O
model	O
for	O
GATA-1	B-protein
expression	O
in	O
differentiating	B-cell_type
hematopoietic	I-cell_type
progenitors	I-cell_type
that	O
involves	O
(	O
i	O
)	O
cycle-dependent	O
initiation	O
and	O
(	O
ii	O
)	O
lineage-dependent	O
maintenance	O
or	O
suppression	O
.	O

Hypothetically	O
,	O
on/off	O
switches	O
of	O
lineage-restricted	B-protein
transactivators	I-protein
may	O
underlie	O
the	O
binary	O
fate	O
decisions	O
of	O
hematopoietic	B-cell_type
progenitors	I-cell_type
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

89	NULL
,	NULL
pp	NULL
.	NULL

6353-6357	NULL
,	NULL
July	NULL
1992	NULL
Cell	NULL
Biology	NULL
Cell	NULL
cycle-dependent	NULL
initiation	NULL
and	NULL
lineage-dependent	NULL
abrogation	NULL
of	NULL
GATA-1	NULL
expression	NULL
in	NULL
pure	NULL
differentiating	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
/erythroid	NULL
and	NULL
myeloid	NULL
development/transcription	NULL
factors	NULL
)	NULL
N.	NULL
M.	NULL
Spost*	NULL
,	NULL
L.	NULL
I.	NULL
Zont	NULL
,	NULL
A.	NULL
Car£*	NULL
,	NULL
M.	NULL
Vautierr*	NULL
,	NULL
U.	NULL
TestaA*	NULL
,	NULL
M.	NULL
GABBIANELLI*	NULL
,	NULL
G.	NULL
MaArIANI®	NULL
,	NULL
L.	NULL
BoTTERO*	NULL
,	NULL
C.	NULL
MaTHERt	NULL
,	NULL
S.	NULL
H.	NULL
Or	NULL
«	NULL
in'tt	NULL
,	NULL
anp	NULL
C.	NULL
Pescnuuse*§	NULL
*Department	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
,	NULL
00161	NULL
Italy	NULL
;	NULL
*Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
The	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
;	NULL
and	NULL
*Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Contributed	NULL
by	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
April	NULL
2	NULL
,	NULL
1992	NULL
ABSTRACT	NULL
The	NULL
programmed	NULL
activation	NULL
/repression	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
early	NULL
hematopoietic	NULL
differentiation	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
explored	NULL
.	NULL

The	NULL
DNA-binding	NULL
protein	NULL
GATA-1	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
erythroid	NULL
development	NULL
and	NULL
regulates	NULL
erythroid-expressed	NULL
genes	NULL
in	NULL
maturing	NULL
erythroblasts	NULL
.	NULL

We	NULL
analyzed	NULL
GATA-1	NULL
expression	NULL
in	NULL
early	NULL
human	NULL
adult	NULL
hematopoiesis	NULL
by	NULL
using	NULL
an	NULL
iz	NULL
vitro	NULL
system	NULL
in	NULL
which	NULL
``	NULL
pure	NULL
``	NULL
early	NULL
hematopoietic	NULL
progenitors	NULL
are	NULL
induced	NULL
to	NULL
gradual	NULL
and	NULL
synchronized	NULL
differentiation	NULL
selectively	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
granulocyte	NULL
,	NULL
macrophage	NULL
pathway	NULL
by	NULL
differential	NULL
treatment	NULL
with	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

The	NULL
GATA-1	NULL
gene	NULL
,	NULL
though	NULL
virtually	NULL
silent	NULL
in	NULL
quiescent	NULL
progenitors	NULL
,	NULL
is	NULL
activated	NULL
after	NULL
entrance	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
upon	NULL
stimulation	NULL
with	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

Subsequently	NULL
,	NULL
increasing	NULL
expression	NULL
along	NULL
the	NULL
erythroid	NULL
pathway	NULL
contrasts	NULL
with	NULL
an	NULL
abrupt	NULL
downregulation	NULL
in	NULL
the	NULL
granulocyte-macrophage	NULL
lineage	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
a	NULL
mi-croenvironment-directed	NULL
,	NULL
two-step	NULL
model	NULL
for	NULL
GATA-1	NULL
expression	NULL
in	NULL
differentiating	NULL
hematopoietic	NULL
progenitors	NULL
that	NULL
involves	NULL
(	NULL
i	NULL
)	NULL
cycle-dependent	NULL
initiation	NULL
and	NULL
(	NULL
i	NULL
)	NULL
lineage-dependent	NULL
maintenance	NULL
or	NULL
suppression	NULL
.	NULL

Hypothetically	NULL
,	NULL
on/off	NULL
switches	NULL
of	NULL
lineage-restricted	NULL
transactivators	NULL
may	NULL
underlie	NULL
the	NULL
binary	NULL
fate	NULL
decisions	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Hematopoiesis	NULL
is	NULL
sustained	NULL
by	NULL
a	NULL
pool	NULL
of	NULL
stem	NULL
cells	NULL
,	NULL
which	NULL
self-renew	NULL
and	NULL
differentiate	NULL
into	NULL
progenitors	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
progenitors	NULL
are	NULL
committed	NULL
to	NULL
specific	NULL
lineages	NULL
and	NULL
are	NULL
functionally	NULL
defined	NULL
as	NULL
colony-forming	NULL
or	NULL
burst-forming	NULL
units	NULL
(	NULL
CFU	NULL
,	NULL
BFU	NULL
)	NULL
of	NULL
the	NULL
erythroid	NULL
series	NULL
(	NULL
CFU-E	NULL
,	NULL
BFU-E	NULL
)	NULL
,	NULL
the	NULL
granu-locyte-monocyte	NULL
lineage	NULL
(	NULL
CFU-GM	NULL
)	NULL
,	NULL
and	NULL
multipotent	NULL
CFU	NULL
for	NULL
the	NULL
GM	NULL
,	NULL
erythroid	NULL
,	NULL
and	NULL
megakaryocytic	NULL
series	NULL
(	NULL
CFU-GEMM	NULL
)	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
progenitors	NULL
in	NULL
turn	NULL
differentiate	NULL
into	NULL
mor-phologically	NULL
recognizable	NULL
precursors	NULL
,	NULL
which	NULL
mature	NULL
to	NULL
terminal	NULL
forms	NULL
circulating	NULL
in	NULL
peripheral	NULL
blood	NULL
.	NULL

Proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
early	NULL
hematopoietic	NULL
cells	NULL
are	NULL
modulated	NULL
by	NULL
specific	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
(	NULL
HGFs	NULL
)	NULL
,	NULL
termed	NULL
colony-stimulating	NULL
factors	NULL
(	NULL
CSFs	NULL
)	NULL
or	NULL
inter-leukins	NULL
(	NULL
ILs	NULL
)	NULL
,	NULL
which	NULL
are	NULL
released	NULL
by	NULL
accessory	NULL
cells	NULL
(	NULL
T	NULL
cells	NULL
,	NULL
large	NULL
granular	NULL
lymphocytes	NULL
,	NULL
monocytes-macrophages	NULL
,	NULL
and	NULL
stromal	NULL
cells	NULL
)	NULL
and	NULL
exert	NULL
a	NULL
multi-	NULL
or	NULL
unilineage	NULL
stimulus	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-3	NULL
(	NULL
5	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
6	NULL
)	NULL
induce	NULL
differentiation	NULL
of	NULL
pluripotent	NULL
(	NULL
CFU-GEMM	NULL
)	NULL
,	NULL
early	NULL
erythroid	NULL
(	NULL
BFU-E	NULL
)	NULL
,	NULL
and	NULL
GM	NULL
progenitors	NULL
(	NULL
CFU-GM	NULL
)	NULL
,	NULL
whereas	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
(	NULL
7	NULL
)	NULL
,	NULL
G-CSF	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
M-CSF	NULL
(	NULL
9	NULL
)	NULL
specifically	NULL
trigger	NULL
differentiation	NULL
of	NULL
late	NULL
erythroid	NULL
(	NULL
CFU-E	NULL
)	NULL
,	NULL
granulocytic	NULL
(	NULL
CFU-G	NULL
)	NULL
,	NULL
and	NULL
monocytic	NULL
(	NULL
CFU-M	NULL
)	NULL
progenitors	NULL
,	NULL
respectively	NULL
.	NULL

Coordinated	NULL
expression	NULL
of	NULL
lineage-specific	NULL
genes	NULL
in	NULL
developing	NULL
hematopoietic	NULL
cells	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
programmed	NULL
activation/suppression	NULL
and	NULL
microenviron-ment-directed	NULL
expression	NULL
of	NULL
tissue-	NULL
and	NULL
stage-specific	NULL
tran	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

6353	NULL
scription	NULL
factors	NULL
.	NULL

As	NULL
a	NULL
transactivator	NULL
whose	NULL
presence	NULL
in	NULL
mature	NULL
hematopoietic	NULL
cells	NULL
is	NULL
limited	NULL
to	NULL
the	NULL
erythroid	NULL
,	NULL
mega-karyocytic	NULL
,	NULL
and	NULL
mast	NULL
lineages	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
GATA-1	NULL
is	NULL
a	NULL
prime	NULL
protein	NULL
for	NULL
study	NULL
in	NULL
this	NULL
context	NULL
.	NULL

GATA-1	NULL
,	NULL
a	NULL
50-kDa	NULL
finger	NULL
protein	NULL
,	NULL
regulates	NULL
erythroid-expressed	NULL
genes	NULL
through	NULL
core	NULL
GATA	NULL
motifs	NULL
(	NULL
12	NULL
)	NULL
and	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
erythroid	NULL
development	NULL
as	NULL
revealed	NULL
by	NULL
gene	NULL
targeting	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Two	NULL
mechanisms	NULL
dependent	NULL
on	NULL
GATA-1	NULL
favor	NULL
maturation	NULL
of	NULL
erythroid	NULL
precursors	NULL
:	NULL
(	NULL
?	NULL
)	NULL

the	NULL
GATA-1	NULL
gene	NULL
is	NULL
autoregulated	NULL
through	NULL
an	NULL
upstream	NULL
GATA	NULL
element	NULL
(	NULL
14	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
GATA-1	NULL
positively	NULL
regulates	NULL
the	NULL
Epo	NULL
receptor	NULL
promoter	NULL
(	NULL
15	NULL
)	NULL
and	NULL
hence	NULL
may	NULL
forestall	NULL
apoptosis	NULL
due	NULL
to	NULL
Epo	NULL
starvation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

While	NULL
aspects	NULL
of	NULL
GATA-1	NULL
regulation	NULL
in	NULL
maturing	NULL
erythroid	NULL
cells	NULL
are	NULL
readily	NULL
reconciled	NULL
with	NULL
its	NULL
proposed	NULL
role	NULL
,	NULL
less	NULL
is	NULL
known	NULL
regarding	NULL
expression	NULL
of	NULL
GATA-1	NULL
in	NULL
early	NULL
progenitors	NULL
.	NULL

The	NULL
IL-3-dependent	NULL
multipotential	NULL
cell	NULL
lines	NULL
FDCPI1	NULL
(	NULL
17	NULL
)	NULL
and	NULL
32D	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
have	NULL
low	NULL
levels	NULL
of	NULL
GATA-1	NULL
expression	NULL
,	NULL
whereas	NULL
levels	NULL
in	NULL
more	NULL
mature	NULL
cell	NULL
lines	NULL
[	NULL
MEL	NULL
(	NULL
erythroid	NULL
)	NULL
,	NULL
CHRF-288	NULL
(	NULL
megakaryocytic	NULL
)	NULL
,	NULL
MC	NULL
/9	NULL
(	NULL
mast	NULL
)	NULL
]	NULL
are	NULL
higher	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
uncertain	NULL
whether	NULL
these	NULL
observations	NULL
on	NULL
immortalized	NULL
cell	NULL
lines	NULL
reflect	NULL
regulation	NULL
of	NULL
GATA-1	NULL
during	NULL
normal	NULL
he-matopoiesis	NULL
.	NULL

We	NULL
analyzed	NULL
GATA-1	NULL
expression	NULL
during	NULL
normal	NULL
hematopoiesis	NULL
by	NULL
using	NULL
an	NULL
in	NULL
vifro	NULL
system	NULL
in	NULL
which	NULL
a	NULL
``	NULL
pure	NULL
``	NULL
population	NULL
of	NULL
early	NULL
progenitors	NULL
(	NULL
19	NULL
)	NULL
undergoes	NULL
a	NULL
gradual	NULL
,	NULL
synchronized	NULL
differentiation	NULL
selectively	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
pathway	NULL
in	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
-free	NULL
liquid	NULL
suspension	NULL
culture	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Progenitor	NULL
Purification	NULL
.	NULL

Human	NULL
hematopoietic	NULL
progenitors	NULL
were	NULL
purified	NULL
from	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
by	NULL
a	NULL
four-step	NULL
procedure	NULL
(	NULL
19	NULL
)	NULL
;	NULL
step	NULL
I	NULL
,	NULL
a	NULL
Ficoll	NULL
cut	NULL
followed	NULL
by	NULL
monocyte	NULL
removal	NULL
(	NULL
plastic	NULL
adherence	NULL
and	NULL
glutamate	NULL
dimeth-yl	NULL
ester	NULL
treatment	NULL
)	NULL
;	NULL
step	NULL
II	NULL
,	NULL
a	NULL
discontinuous	NULL
Percoll	NULL
density	NULL
gradient	NULL
to	NULL
separate	NULL
the	NULL
low-density	NULL
cells	NULL
;	NULL
step	NULL
III	NULL
,	NULL
negative	NULL
selection	NULL
with	NULL
immunomagnetic	NULL
beads	NULL
and	NULL
a	NULL
panel	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAbs	NULL
)	NULL
against	NULL
T	NULL
,	NULL
B	NULL
,	NULL
and	NULL
natural	NULL
killer	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
;	NULL
step	NULL
IV	NULL
,	NULL
positive	NULL
selection	NULL
with	NULL
immunomagnetic	NULL
beads	NULL
and	NULL
anti-CD34	NULL
mAb	NULL
.	NULL

The	NULL
procedure	NULL
was	NULL
slightly	NULL
modified	NULL
:	NULL
step	NULL
I	NULL
,	NULL
glutamate	NULL
dimethyl	NULL
]	NULL
ester	NULL
treatment	NULL
was	NULL
omitted	NULL
;	NULL
step	NULL
II	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
purified	NULL
on	NULL
a	NULL
four-step	NULL
(	NULL
rather	NULL
than	NULL
three-step	NULL
)	NULL
Percoll	NULL
gradient	NULL
(	NULL
3-ml	NULL
frac-	NULL
Abbreviations	NULL
:	NULL
BFU-E	NULL
,	NULL
erythroid	NULL
burst-forming	NULL
unit	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CFU	NULL
,	NULL
colony-forming	NULL
unit	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CSF	NULL
,	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
GM	NULL
,	NULL
granulo-cyte-monocyte	NULL
;	NULL
Epo	NULL
,	NULL
erythropoietin	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
HGF	NULL
,	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
RT	NULL
,	NULL
reverse	NULL
transcriptase	NULL
;	NULL
FITC	NULL
,	NULL
fluorescein	NULL
isothio-cyanate	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Department	NULL
of	NULL
Hematology-Oncology-Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Viale	NULL
Regina	NULL
Elena	NULL
,	NULL
299	NULL
,	NULL
00161	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

6354	NULL
Cell	NULL
Biology	NULL
:	NULL
Sposi	NULL
et	NULL
al	NULL
.	NULL

tions	NULL
:	NULL
1.052	NULL
,	NULL
1.056	NULL
,	NULL
1.059	NULL
,	NULL
and	NULL
1.065	NULL
g/ml	NULL
)	NULL
.	NULL

Cells	NULL
of	NULL
density	NULL
=	NULL
1.056	NULL
g/ml	NULL
were	NULL
recovered	NULL
and	NULL
further	NULL
processed	NULL
.	NULL

Liquid	NULL
Suspension	NULL
Culture	NULL
.	NULL

Step	NULL
IV	NULL
progenitors	NULL
were	NULL
grown	NULL
at	NULL
104	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
(	NULL
IMDM	NULL
)	NULL
without	NULL
FBS	NULL
and	NULL
supplemented	NULL
(	NULL
20	NULL
)	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
10	NULL
mg/ml	NULL
)	NULL
,	NULL
human	NULL
transferrin	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
,	NULL
human	NULL
low	NULL
density	NULL
lipoproteins	NULL
(	NULL
40	NULL
ug/mi	NULL
)	NULL
,	NULL
insulin	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
sodium	NULL
pyruvate	NULL
(	NULL
0.1	NULL
mM	NULL
)	NULL
,	NULL
L-glutamine	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
,	NULL
rare	NULL
inorganic	NULL
elements	NULL
(	NULL
ref	NULL
.	NULL

21	NULL
)	NULL
,	NULL
ferrous	NULL
sulfate	NULL
(	NULL
40	NULL
mM	NULL
)	NULL
,	NULL
nucleosides	NULL
(	NULL
each	NULL
at	NULL
10	NULL
ug/mi	NULL
)	NULL
,	NULL
and	NULL
recombinant	NULL
human	NULL
HGFs	NULL
[	NULL
for	NULL
GM	NULL
differentiation	NULL
culture	NULL
,	NULL
high	NULL
doses	NULL
of	NULL
IL-3	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
;	NULL
for	NULL
erythroid	NULL
differentiation	NULL
culture	NULL
,	NULL
low	NULL
doses	NULL
of	NULL
IL-3	NULL
(	NULL
0.01	NULL
unit/ml	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
0.001	NULL
ng/ml	NULL
)	NULL
and	NULL
a	NULL
plateau	NULL
level	NULL
of	NULL
Epo	NULL
(	NULL
3	NULL
units/ml	NULL
)	NULL
]	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
fully	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
/5	NULL
%	NULL
0	NULL
;	NULL
/90	NULL
%	NULL
N	NULL
;	NULL
and	NULL
were	NULL
periodically	NULL
counted	NULL
,	NULL
harvested	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
cell	NULL
cycling	NULL
,	NULL
membrane	NULL
pheno-type	NULL
,	NULL
and	NULL
morphology	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
proliferative	NULL
potential	NULL
of	NULL
the	NULL
progenitors	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
periodically	NULL
plated	NULL
in	NULL
FBS-containing	NULL
methylcellulose	NULL
cultures	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
(	NULL
HGFs	NULL
including	NULL
saturating	NULL
doses	NULL
of	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
Epo	NULL
)	NULL
;	NULL
on	NULL
day	NULL
14	NULL
the	NULL
colonies	NULL
were	NULL
scored	NULL
individually	NULL
,	NULL
picked	NULL
up	NULL
,	NULL
washed	NULL
,	NULL
resuspended	NULL
,	NULL
and	NULL
counted	NULL
.	NULL

Clonogenic	NULL
Assay	NULL
.	NULL

The	NULL
assay	NULL
(	NULL
19	NULL
)	NULL
was	NULL
performed	NULL
in	NULL
FBS-containing	NULL
methylcellulose	NULL
culture	NULL
supplemented	NULL
with	NULL
recombinant	NULL
HGFs	NULL
{	NULL
IL-3	NULL
(	NULL
100	NULL
units/ml	NULL
,	NULL
Genetics	NULL
Institute	NULL
,	NULL
Boston	NULL
)	NULL
,	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

,	NULL
Genetics	NULL
Institute	NULL
)	NULL
,	NULL
and	NULL
Epo	NULL
(	NULL
3	NULL
units/ml	NULL
,	NULL
Amgen	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
c-Kit	NULL
ligand	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
Im-munex	NULL
)	NULL
,	NULL
replacing	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
]	NULL
.	NULL

Cell	NULL
Surface	NULL
Markers	NULL
.	NULL

Expression	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
was	NULL
evaluated	NULL
by	NULL
double	NULL
immunofluorescence	NULL
using	NULL
a	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
anti-CD34	NULL
mAb	NULL
(	NULL
8G12	NULL
clone	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Lansdorp	NULL
,	NULL
Terry	NULL
Fox	NULL
Laboratories	NULL
,	NULL
Vancouver	NULL
)	NULL
and	NULL
various	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
mAbs	NULL
,	NULL
including	NULL
anti-CD45RO	NULL
(	NULL
UCHL-1	NULL
clone	NULL
,	NULL
Dakopatts	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
,	NULL
anti-HLA-DR	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
and	NULL
anti-CD33	NULL
(	NULL
Silenus	NULL
,	NULL
Paris	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
appropriate	NULL
dilution	NULL
of	NULL
mAbs	NULL
,	NULL
wt	NULL
5	NULL
a	NULL
Control	NULL
(	NULL
PE	NULL
)	NULL
--	NULL
»	NULL
3	NULL
Anti-	NULL
HLA-	NULL
DR	NULL
3	NULL
,	NULL
1	NULL
Anti-	NULL
CD45RO	NULL
Anti-	NULL
CD33	NULL
|	NULL
/	NULL
(	NULL
l	NULL
!	NULL

I|	NULL
Anti-	NULL
CD34/8G12	NULL
Anti-	NULL
CD34/8	NULL
G12	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Membrane	NULL
phenotype	NULL
of	NULL
pure	NULL
(	NULL
step	NULL
IV	NULL
)	NULL
hematopoietic	NULL
progenitors	NULL
from	NULL
human	NULL
adult	NULL
peripheral	NULL
blood	NULL
(	NULL
19	NULL
)	NULL
as	NULL
evaluated	NULL
by	NULL
double	NULL
immunofluorescence	NULL
.	NULL

The	NULL
purification	NULL
index	NULL
of	NULL
the	NULL
progenitors	NULL
(	NULL
CFU-GEMM	NULL
,	NULL
BFU-E	NULL
,	NULL
CFU-GM	NULL
)	NULL
,	NULL
as	NULL
evaluated	NULL
in	NULL
FBS-containing	NULL
methylcellulose	NULL
culture	NULL
(	NULL
100	NULL
cells	NULL
per	NULL
dish	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
c-Kit	NULL
ligand	NULL
,	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
Epo	NULL
)	NULL
was	NULL
88	NULL
%	NULL
(	NULL
cf	NULL
.	NULL

refs	NULL
.	NULL

19	NULL
and	NULL
25	NULL
)	NULL
.	NULL

The	NULL
progenitors	NULL
are	NULL
essentially	NULL
quiescent	NULL
(	NULL
[	NULL
°H	NULL
]	NULL
Jthymidine	NULL
suicide	NULL
index	NULL
,	NULL
<	NULL
5	NULL
%	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
give	NULL
rise	NULL
to	NULL
large	NULL
colonies	NULL
in	NULL
clonogenetic	NULL
culture	NULL
even	NULL
without	NULL
addition	NULL
of	NULL
c-Kit	NULL
ligand	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
progenitors	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
liquid	NULL
phase	NULL
for	NULL
selective	NULL
erythroid	NULL
or	NULL
GM	NULL
differentiation	NULL
(	NULL
Figs	NULL
.	NULL

2-4	NULL
)	NULL
and	NULL
finally	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
for	NULL
GATA-1	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
consistently	NULL
confirmed	NULL
in	NULL
several	NULL
separate	NULL
experiments	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
cold	NULL
Hanks	NULL
'	NULL
saline	NULL
solution	NULL
containing	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
2	NULL
mg/ml	NULL
;	NULL
fraction	NULL
V	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
suspended	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
with	NULL
2.5	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
for-malin	NULL
,	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
using	NULL
the	NULL
Lysis	NULL
program	NULL
for	NULL
analysis	NULL
of	NULL
double	NULL
fluorescence	NULL
.	NULL

Cell	NULL
Cycle	NULL
Analysis	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
percent	NULL
killing	NULL
of	NULL
progenitors	NULL
after	NULL
incubation	NULL
with	NULL
was	NULL
evaluated	NULL
as	NULL
described	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
10°	NULL
cells	NULL
from	NULL
each	NULL
sample	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
tubes	NULL
containing	NULL
IMDM	NULL
.	NULL

Tubes	NULL
II	NULL
and	NULL
III	NULL
contained	NULL
20	NULL
and	NULL
100	NULL
mCi	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
GM	NULL
DIFFERENTIATION	NULL
3H-TdR	NULL
suicide	NULL
killing	NULL
(	NULL
%	NULL
)	NULL
4	NULL
10	NULL
ERYTHAROID	NULL
DIFFERENTIATION	NULL
r	NULL
--	NULL
--	NULL
r	NULL
--	NULL
-	NULL
10	NULL
?	NULL

Cell	NULL
Number	NULL
5	NULL
10	NULL
ERYTHAOID	NULL
DIFFERENTIATION	NULL
10	NULL
4	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Pure	NULL
(	NULL
step	NULL
IV	NULL
)	NULL
progenitors	NULL
undergo	NULL
a	NULL
wave	NULL
of	NULL
gradual/	NULL
synchronous	NULL
differentiation	NULL
selectively	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
pathway	NULL
in	NULL
FBS-free	NULL
liquid	NULL
suspension	NULL
culture	NULL
supplemented	NULL
with	NULL
appropriate	NULL
HGFs	NULL
at	NULL
day	NULL
0	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
[	NULL
PH	NULL
]	NULL
Thymidine	NULL
CH-TdR	NULL
)	NULL
suicide	NULL
index	NULL
(	NULL
%	NULL
)	NULL
of	NULL
progenitors	NULL
in	NULL
the	NULL
erythroid	NULL
(	NULL
®	NULL
)	NULL
and	NULL
GM	NULL
(	NULL
0	NULL
)	NULL
differentiation	NULL
cultures	NULL
at	NULL
days	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
after	NULL
HGF	NULL
stimulus	NULL
.	NULL

(	NULL
Middle	NULL
)	NULL
Growth	NULL
curve	NULL
in	NULL
erythroid	NULL
(	NULL
@	NULL
)	NULL
and	NULL
GM	NULL
(	NULL
0	NULL
)	NULL
differentiation	NULL
cultures	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Size	NULL
of	NULL
colonies	NULL
(	NULL
cells	NULL
per	NULL
colony	NULL
)	NULL
generated	NULL
by	NULL
erythroid	NULL
(	NULL
BFU-E	NULL
,	NULL
m	NULL
)	NULL
and	NULL
GM	NULL
(	NULL
CFU-GM	NULL
,	NULL
o	NULL
)	NULL
progenitors	NULL
obtained	NULL
at	NULL
sequential	NULL
days	NULL
from	NULL
the	NULL
erythroid	NULL
and	NULL
GM	NULL
differentiation	NULL
cultures	NULL
.	NULL

Cell	NULL
Biology	NULL
:	NULL
Sposi	NULL
et	NULL
al	NULL
.	NULL

Lu	NULL
Control	NULL
(	NULL
PE	NULL
)	NULL
--	NULL
»	NULL
%	NULL
1	NULL
Anti-	NULL
HLA-DR	NULL
(	NULL
PE	NULL
)	NULL
--	NULL
»	NULL
10°	NULL
1	NULL
1*	NULL
Control	NULL
(	NULL
FITC	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Anti-	NULL
CD4S	NULL
RO	NULL
(	NULL
PE	NULL
)	NULL
--	NULL
»	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
6355	NULL
Day	NULL
3	NULL
Anti-	NULL
CD33	NULL
(	NULL
PE	NULL
)	NULL
--	NULL
Anti-	NULL
CD34/8G12	NULL
(	NULL
FITC	NULL
)	NULL
--	NULL
»	NULL
Membrane	NULL
phenotype	NULL
of	NULL
progenitors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
liquid	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
legend	NULL
)	NULL
,	NULL
harvested	NULL
at	NULL
sequential	NULL
days	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
double	NULL
immunofluorescence	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
legend	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
are	NULL
observed	NULL
in	NULL
the	NULL
liquid	NULL
GM	NULL
culture	NULL
system	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

midine	NULL
(	NULL
20	NULL
Ci/mmol	NULL
,	NULL
New	NULL
England	NULL
Nuclear	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
)	NULL
,	NULL
and	NULL
tube	NULL
IV	NULL
contained	NULL
200	NULL
ug	NULL
of	NULL
nonradioactive	NULL
thymidine	NULL
(	NULL
Serva	NULL
)	NULL
and	NULL
20	NULL
LCi	NULL
of	NULL
PHJthymidine	NULL
.	NULL

After	NULL
20	NULL
min	NULL
of	NULL
incubation	NULL
in	NULL
a	NULL
water	NULL
bath	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
thymidine	NULL
(	NULL
200	NULL
and	NULL
40	NULL
ug/ml	NULL
)	NULL
with	NULL
IMDM	NULL
containing	NULL
2	NULL
%	NULL
FBS	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
cell	NULL
death	NULL
between	NULL
tubes	NULL
II	NULL
and	NULL
III	NULL
or	NULL
tubes	NULL
I	NULL
and	NULL
IV	NULL
.	NULL

The	NULL
cells	NULL
from	NULL
each	NULL
tube	NULL
were	NULL
plated	NULL
(	NULL
100	NULL
cells	NULL
per	NULL
dish	NULL
)	NULL
for	NULL
assay	NULL
of	NULL
progenitors	NULL
in	NULL
FBS-containing	NULL
methylcellulose	NULL
cultures	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

The	NULL
fraction	NULL
of	NULL
precursors	NULL
killed	NULL
by	NULL
[	NULL
PH	NULL
]	NULL
thymidine	NULL
was	NULL
calculated	NULL
as	NULL
1	NULL
-	NULL
T/C	NULL
(	NULL
T	NULL
,	NULL
total	NULL
colonies	NULL
from	NULL
dishes	NULL
II	NULL
and	NULL
III	NULL
;	NULL
C	NULL
,	NULL
total	NULL
colonies	NULL
from	NULL
dishes	NULL
I	NULL
and	NULL
IV	NULL
)	NULL
.	NULL

Reverse	NULL
Transcriptase-Polymerase	NULL
Chain	NULL
Reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
Analysis	NULL
,	NULL
Total	NULL
RNA	NULL
extracted	NULL
by	NULL
the	NULL
guanidinium	NULL
isothiocyanate/CsCl	NULL
method	NULL
(	NULL
24	NULL
)	NULL
from	NULL
the	NULL
same	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
12	NULL
ug	NULL
of	NULL
Escherichia	NULL
coli	NULL
rRNA	NULL
was	NULL
quantitated	NULL
by	NULL
dot	NULL
hybridization	NULL
with	NULL
a	NULL
human	NULL
rRNA	NULL
probe	NULL
.	NULL

After	NULL
densitometric	NULL
analysis	NULL
the	NULL
normalized	NULL
amount	NULL
of	NULL
RNA	NULL
was	NULL
reverse-transcribed	NULL
(	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
RT	NULL
,	NULL
BRL	NULL
)	NULL
with	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
as	NULL
primer	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
each	NULL
RT	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-	NULL
>	NULL
P	NULL
]	NULL
JdCTP	NULL
tracer	NULL
and	NULL
the	NULL
reverse-transcribed	NULL
RNA-DNA	NULL
was	NULL
normalized	NULL
accordingly	NULL
.	NULL

Amplification	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
was	NULL
achieved	NULL
by	NULL
20	NULL
cycles	NULL
of	NULL
PCR	NULL
consisting	NULL
of	NULL
denaturation	NULL
at	NULL
95°C	NULL
for	NULL
1.5	NULL
min	NULL
,	NULL
annealing	NULL
at	NULL
52°C	NULL
for	NULL
1.5	NULL
min	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
1.5	NULL
min	NULL
.	NULL

Primers	NULL
for	NULL
GATA-1	NULL
(	NULL
25	NULL
)	NULL
were	NULL
5S-TTAGCCACCTCATGCCTT-3	NULL
'	NULL
and	NULL
5'-ACATCGGTCTTAAGACCT-3	NULL
'	NULL
and	NULL
generated	NULL
a	NULL
PCR	NULL
product	NULL
of	NULL
194	NULL
base	NULL
pairs	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
Ll	NULL
,	NULL
and	NULL
10	NULL
pl	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
filter	NULL
for	NULL
hybridization	NULL
with	NULL
an	NULL
internal	NULL
40-mer	NULL
GATA-1	NULL
probe	NULL
(	NULL
5'-TACTGTGGTGGCTCCGCTCAGCTCATGAGGCACA-	NULL
In	NULL
control	NULL
experiments	NULL
,	NULL
serial	NULL
dilutions	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
amplified	NULL
;	NULL
the	NULL
dose-response	NULL
curves	NULL
showed	NULL
linearity	NULL
for	NULL
all	NULL
points	NULL
.	NULL

Relative	NULL
intensities	NULL
of	NULL
bands	NULL
were	NULL
quantified	NULL
by	NULL
scanning	NULL
with	NULL
a	NULL
laser	NULL
densitometer	NULL
(	NULL
LKB	NULL
)	NULL
.	NULL

GATA-1	NULL
Gel	NULL
Shift	NULL
Assay	NULL
.	NULL

Since	NULL
this	NULL
analysis	NULL
requires	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cells	NULL
,	NULL
step	NULL
III	NULL
progenitors	NULL
were	NULL
utilized	NULL
(	NULL
see	NULL
refs	NULL
.	NULL

19	NULL
and	NULL
25	NULL
)	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
(	NULL
26	NULL
)	NULL
and	NULL
gel	NULL
shift	NULL
analysis	NULL
(	NULL
15	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
0.27-1	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
time	NULL
point	NULL
.	NULL

Incubation	NULL
mixtures	NULL
(	NULL
20	NULL
pl	NULL
)	NULL
contained	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
Epo	NULL
receptor	NULL
promoter	NULL
probe	NULL
(	NULL
5-10	NULL
x	NULL
10	NULL
}	NULL
dpm/ng	NULL
)	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
2-6	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Bands	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
Phosphorimager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Phenotype	NULL
of	NULL
Purified	NULL
Progenitors	NULL
.	NULL

Hematopoietic	NULL
progenitors	NULL
were	NULL
purified	NULL
from	NULL
normal	NULL
adult	NULL
peripheral	NULL
blood	NULL
by	NULL
a	NULL
four-step	NULL
procedure	NULL
(	NULL
19	NULL
)	NULL
;	NULL
the	NULL
final	NULL
index	NULL
of	NULL
purification	NULL
is	NULL
~90	NULL
%	NULL
and	NULL
the	NULL
yield	NULL
is	NULL
~20	NULL
%	NULL
(	NULL
ref	NULL
.	NULL

19	NULL
and	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

6356	NULL
Cell	NULL
Biology	NULL
:	NULL
Sposi	NULL
et	NULL
al	NULL
.	NULL

ERYTHROID	NULL
DIFFERENTIATION	NULL
100	NULL
CD34+	NULL
47-004	NULL
80	NULL
60	NULL
<	NULL
-GPA*	NULL
40	NULL
20	NULL
0	NULL
GM	NULL
DIFFERENTIATION	NULL
%	NULL
total	NULL
100	NULL
rCDM	NULL
``	NULL
8	NULL
kcmzr	NULL
%	NULL
total	NULL
8	NULL
8	NULL
8	NULL
o	NULL
2	NULL
4	NULL
60	NULL
8	NULL
do	NULL
d2	NULL
G40	NULL
00	NULL
20	NULL
40	NULL
60	NULL
8	NULL
10	NULL
12	NULL
14	NULL
Days	NULL
Days	NULL
o	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Gradual	NULL
decline	NULL
of	NULL
CD34*	NULL
(	NULL
@	NULL
)	NULL
and	NULL
appearance	NULL
of	NULL
lineage-specific	NULL
markers	NULL
(	NULL
0	NULL
)	NULL
on	NULL
progenitors	NULL
grown	NULL
in	NULL
erythroid	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
GM	NULL
(	NULL
Lower	NULL
)	NULL
liquid	NULL
culture	NULL
system	NULL
as	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
legend	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
differentiated	NULL
erythroid	NULL
or	NULL
GM	NULL
cells	NULL
in	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
culture	NULL
system	NULL
was	NULL
monitored	NULL
with	NULL
an	NULL
anti-glycophorin	NULL
A	NULL
(	NULL
GPA	NULL
)	NULL
(	NULL
Ortho	NULL
Diagnostics	NULL
,	NULL
Raritan	NULL
,	NULL
NJ	NULL
)	NULL
or	NULL
anti-CD13	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
mAb	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Morphologic	NULL
analysis	NULL
of	NULL
progenitors	NULL
differentiating	NULL
in	NULL
liquid	NULL
erythroid	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
GM	NULL
(	NULL
Lower	NULL
)	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
days	NULL
,	NULL
smeared	NULL
on	NULL
glass	NULL
slides	NULL
by	NULL
Cytospin	NULL
centrifugation	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
May-Grimwald/Giemsa	NULL
reagents	NULL
.	NULL

For	NULL
erythroid	NULL
cultures	NULL
:	NULL
®	NULL
,	NULL
blasts	NULL
;	NULL
0	NULL
,	NULL
proerythroblasts	NULL
and	NULL
basophilic	NULL
erythroblasts	NULL
;	NULL
0	NULL
,	NULL
polychromophilic	NULL
erythroblasts	NULL
;	NULL
a	NULL
,	NULL
orthochromophilic	NULL
erythroblasts	NULL
.	NULL

For	NULL
GM	NULL
cultures	NULL
:	NULL
e	NULL
,	NULL
blasts	NULL
;	NULL
a	NULL
,	NULL
immature	NULL
GM	NULL
cells	NULL
;	NULL
0	NULL
,	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
;	NULL
G	NULL
,	NULL
monocytes	NULL
.	NULL

Mast	NULL
cells	NULL
and	NULL
megakaryocytes	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
either	NULL
the	NULL
erythroid	NULL
or	NULL
the	NULL
GM	NULL
culture	NULL
system	NULL
.	NULL

These	NULL
highly	NULL
undifferentiated	NULL
progenitors	NULL
(	NULL
CFU-GEMM	NULL
,	NULL
BFU-E	NULL
,	NULL
CFU-GM	NULL
)	NULL
are	NULL
largely	NULL
quiescent	NULL
,	NULL
give	NULL
rise	NULL
to	NULL
large	NULL
colonies	NULL
in	NULL
clonogenic	NULL
culture	NULL
,	NULL
and	NULL
consist	NULL
of	NULL
a	NULL
population	NULL
that	NULL
is	NULL
=~90	NULL
%	NULL
CD34*	NULL
,	NULL
80-90	NULL
%	NULL
HLA-DR	NULL
+	NULL
,	NULL
<	NULL
10	NULL
%	NULL
CD45RO*	NULL
,	NULL
and	NULL
<	NULL
10	NULL
%	NULL
CD33*	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
marrow	NULL
progenitors	NULL
are	NULL
mostly	NULL
CD34+*33*	NULL
:	NULL
the	NULL
small	NULL
CD34+*33~	NULL
population	NULL
includes	NULL
the	NULL
earliest	NULL
progenitors	NULL
and	NULL
stem	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Further-more	NULL
,	NULL
the	NULL
purified	NULL
progenitors	NULL
comprise	NULL
a	NULL
small	NULL
population	NULL
of	NULL
multipotent	NULL
progenitors	NULL
with	NULL
self-renewal	NULL
capacity-i.e	NULL
.	NULL

,	NULL
with	NULL
stem-cell	NULL
properties	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
adult	NULL
blood	NULL
mononu-clear	NULL
or	NULL
CD34*	NULL
cells	NULL
can	NULL
reconstitute	NULL
the	NULL
hematolymphopoi-etic	NULL
system	NULL
when	NULL
transplanted	NULL
in	NULL
patients	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
or	NULL
monkeys	NULL
(	NULL
20	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Kinetics	NULL
of	NULL
Pure	NULL
Progenitors	NULL
'	NULL
Proliferation	NULL
and	NULL
Differentiation	NULL
.	NULL

The	NULL
pure	NULL
progenitors	NULL
,	NULL
triggered	NULL
into	NULL
cycling	NULL
by	NULL
HGFs	NULL
in	NULL
FBS-free	NULL
liquid	NULL
suspension	NULL
culture	NULL
,	NULL
undergo	NULL
extensive	NULL
proliferation	NULL
coupled	NULL
with	NULL
a	NULL
wave	NULL
of	NULL
gradual	NULL
and	NULL
synchronized	NULL
differentiation	NULL
,	NULL
which	NULL
takes	NULL
place	NULL
selectively	NULL
along	NULL
either	NULL
the	NULL
GM	NULL
pathway	NULL
(	NULL
upon	NULL
treatment	NULL
with	NULL
high	NULL
doses	NULL
of	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
)	NULL
or	NULL
the	NULL
erythroid	NULL
pathway	NULL
(	NULL
upon	NULL
addition	NULL
of	NULL
low	NULL
amounts	NULL
of	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
and	NULL
saturating	NULL
levels	NULL
of	NULL
Epo	NULL
)	NULL
(	NULL
representative	NULL
results	NULL
in	NULL
Figs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
first	NULL
week	NULL
of	NULL
culture	NULL
the	NULL
progenitors	NULL
show	NULL
both	NULL
a	NULL
gradual	NULL
decrease	NULL
of	NULL
their	NULL
proliferative	NULL
potential	NULL
(	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
progressive	NULL
decline	NULL
of	NULL
the	NULL
size	NULL
of	NULL
the	NULL
progenitor-generated	NULL
colonies	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
Bottom	NULL
)	NULL
and	NULL
a	NULL
homogeneous	NULL
shift	NULL
of	NULL
their	NULL
membrane	NULL
phenotype	NULL
(	NULL
as	NULL
indicated	NULL
by	NULL
double	NULL
labeling	NULL
experiments	NULL
with	NULL
CD34/33	NULL
and	NULL
CD34/45RO	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
they	NULL
undergo	NULL
a	NULL
wave	NULL
of	NULL
gradual	NULL
and	NULL
synchronized	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
ay	NULL
a	NULL
)	NULL
Ss	NULL
#	NULL
i	NULL
«	NULL
ties	NULL
-	NULL
ails	NULL
whs	NULL
-	NULL
a	NULL
.	NULL

Erythroid	NULL
GM	NULL
K	NULL
56	NULL
Day	NULL
Day	NULL
wth	NULL
=	NULL
oon	NULL
_	NULL
ww	NULL
.	NULL

«	NULL
--	NULL
#	NULL
P	NULL
#	NULL
Erythroid	NULL
GM	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
GATA-1	NULL
mRNA	NULL
expression	NULL
in	NULL
pure	NULL
(	NULL
step	NULL
IV	NULL
)	NULL
progenitors	NULL
and	NULL
their	NULL
progeny	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
differentiation	NULL
liquid	NULL
culture	NULL
system	NULL
,	NULL
evaluated	NULL
by	NULL
RT-PCR	NULL
.	NULL

K562	NULL
,	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Dose-response	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
expression	NULL
in	NULL
step	NULL
IV	NULL
progenitors	NULL
and	NULL
their	NULL
progeny	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
differentiation	NULL
liquid	NULL
culture	NULL
system	NULL
.	NULL

Serial	NULL
dilutions	NULL
(	NULL
1:10	NULL
,	NULL
1:5	NULL
,	NULL
1:1	NULL
)	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
amplified	NULL
.	NULL

In	NULL
the	NULL
second	NULL
week	NULL
of	NULL
culture	NULL
,	NULL
progressive	NULL
expression	NULL
of	NULL
specific	NULL
markers	NULL
of	NULL
differentiated	NULL
erythroid	NULL
or	NULL
GM	NULL
precursors	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
glycophorin	NULL
A	NULL
and	NULL
CD13	NULL
,	NULL
respectively	NULL
)	NULL
is	NULL
observed	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
converse	NULL
decline	NULL
of	NULL
the	NULL
frequency	NULL
of	NULL
CD34*	NULL
cells	NULL
to	NULL
undetectable	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
Left	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
cell	NULL
morphology	NULL
shows	NULL
a	NULL
gradual	NULL
wave	NULL
of	NULL
differentiation	NULL
selectively	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
pathway	NULL
to	NULL
terminal	NULL
differentiation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
Right	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
differentiated	NULL
cells	NULL
exhibit	NULL
virtually	NULL
normal	NULL
morphologic	NULL
features	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

FiG	NULL
.	NULL

6	NULL
.	NULL

-	NULL
GATA-1	NULL
in	NULL
step	NULL
III	NULL
purified	NULL
progenitors	NULL
and	NULL
their	NULL
progeny	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
differentiation	NULL
liquid	NULL
culture	NULL
system	NULL
,	NULL
evaluated	NULL
by	NULL
gel	NULL
mobility-shift	NULL
analysis	NULL
with	NULL
a	NULL
probe	NULL
derived	NULL
from	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
Epo	NULL
receptor	NULL
(	NULL
nucleotides	NULL
-61	NULL
to	NULL
-28	NULL
)	NULL
and	NULL
encompassing	NULL
the	NULL
region	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
.	NULL

(	NULL
Leff	NULL
)	NULL
Lanes	NULL
:	NULL
1	NULL
,	NULL
day	NULL
0	NULL
;	NULL
2	NULL
,	NULL
erythroid	NULL
culture	NULL
day	NULL
1	NULL
;	NULL
3	NULL
,	NULL
GM	NULL
culture	NULL
day	NULL
1	NULL
;	NULL
4	NULL
,	NULL
erythroid	NULL
day	NULL
3	NULL
;	NULL
5	NULL
,	NULL
GM	NULL
day	NULL
3	NULL
;	NULL
6	NULL
,	NULL
erythroid	NULL
day	NULL
7	NULL
;	NULL
7	NULL
,	NULL
GM	NULL
day	NULL
7	NULL
;	NULL
8	NULL
,	NULL
erythroid	NULL
day	NULL
13	NULL
;	NULL
9	NULL
,	NULL
GM	NULL
day	NULL
13	NULL
;	NULL
10	NULL
and	NULL
11	NULL
,	NULL
negative	NULL
controls	NULL
;	NULL
12	NULL
,	NULL
K562	NULL
positive	NULL
control	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Gel	NULL
shift	NULL
assay	NULL
using	NULL
extract	NULL
from	NULL
day	NULL
3	NULL
cultures	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
K562	NULL
positive	NULL
control	NULL
;	NULL
2	NULL
,	NULL
erythroid	NULL
culture	NULL
day	NULL
3	NULL
;	NULL
3	NULL
,	NULL
GM	NULL
culture	NULL
day	NULL
3	NULL
;	NULL
4	NULL
,	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
purification	NULL
of	NULL
the	NULL
step	NULL
III	NULL
progenitors	NULL
was	NULL
39	NULL
%	NULL
(	NULL
Left	NULL
)	NULL
and	NULL
27	NULL
%	NULL
(	NULL
Right	NULL
)	NULL
.	NULL

GATA-1	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
CD34~-cells	NULL
purified	NULL
from	NULL
step	NULL
III	NULL
progenitors	NULL
and	NULL
grown	NULL
for	NULL
3	NULL
days	NULL
in	NULL
the	NULL
GM	NULL
culture	NULL
system	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
Biology	NULL
:	NULL
Sposi	NULL
et	NULL
al	NULL
.	NULL

RT-PCR	NULL
Analysis	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
Differentiating	NULL
Pure	NULL
Progenitors	NULL
.	NULL

We	NULL
utilized	NULL
this	NULL
in	NULL
vitro	NULL
model	NULL
to	NULL
evaluate	NULL
the	NULL
expression	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
in	NULL
progenitors	NULL
differentiating	NULL
along	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
pathway	NULL
(	NULL
representative	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
GATA-1	NULL
gene	NULL
is	NULL
barely	NULL
expressed	NULL
in	NULL
the	NULL
starting	NULL
population	NULL
of	NULL
quiescent	NULL
progenitor/	NULL
stem	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
induces	NULL
cell	NULL
proliferation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
coupled	NULL
to	NULL
initiation	NULL
of	NULL
GATA-1	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
initial	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
may	NULL
be	NULL
directly	NULL
related	NULL
to	NULL
the	NULL
cycling	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
erythroid	NULL
differentiation	NULL
pathway	NULL
GATA-1	NULL
mRNA	NULL
expression	NULL
is	NULL
maintained	NULL
and	NULL
gradually	NULL
enhanced	NULL
through	NULL
the	NULL
terminal	NULL
stages	NULL
of	NULL
maturation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Differentiation	NULL
along	NULL
the	NULL
GM	NULL
pathway	NULL
is	NULL
initially	NULL
associated	NULL
with	NULL
GATA-1	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
then	NULL
abruptly	NULL
down-regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
late	NULL
progenitors/early	NULL
differentiated	NULL
precursors	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

It	NULL
must	NULL
be	NULL
emphasized	NULL
that	NULL
both	NULL
mast	NULL
cells	NULL
and	NULL
megakaryocytes	NULL
are	NULL
absent	NULL
from	NULL
the	NULL
GM	NULL
culture	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
a	NULL
series	NULL
of	NULL
controls	NULL
including	NULL
dose-response	NULL
curves	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
ensured	NULL
a	NULL
semi-quantitative	NULL
evaluation	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
by	NULL
RT-PCR	NULL
(	NULL
see	NULL
also	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Gel	NULL
Shift	NULL
Analysis	NULL
of	NULL
GATA-1	NULL
Protein	NULL
in	NULL
Differentiating	NULL
Pure	NULL
Progenitors	NULL
.	NULL

We	NULL
performed	NULL
gel	NULL
shift	NULL
assays	NULL
using	NULL
a	NULL
GATA	NULL
target	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
Epo	NULL
receptor	NULL
gene	NULL
promoter	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
prepared	NULL
from	NULL
~30	NULL
%	NULL
purified	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
grown	NULL
in	NULL
the	NULL
erythroid	NULL
or	NULL
GM	NULL
culture	NULL
system	NULL
.	NULL

GATA-1	NULL
present	NULL
in	NULL
K562	NULL
cell	NULL
extract	NULL
forms	NULL
a	NULL
specific	NULL
complex	NULL
on	NULL
the	NULL
Epo	NULL
receptor	NULL
probe	NULL
(	NULL
ref	NULL
.	NULL

15	NULL
;	NULL
Fig	NULL
.	NULL

6	NULL
Left	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
is	NULL
not	NULL
detected	NULL
when	NULL
extract	NULL
from	NULL
the	NULL
purified	NULL
,	NULL
quiescent	NULL
progenitors	NULL
is	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Left	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
but	NULL
is	NULL
initially	NULL
detected	NULL
in	NULL
the	NULL
differentiated	NULL
progenitors	NULL
after	NULL
3	NULL
days	NULL
in	NULL
erythroid	NULL
or	NULL
GM	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Right	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
day	NULL
7	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
complex	NULL
is	NULL
evident	NULL
only	NULL
in	NULL
the	NULL
erythroid	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Left	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
and	NULL
then	NULL
progressively	NULL
increases	NULL
during	NULL
erythroid	NULL
maturation	NULL
up	NULL
to	NULL
day	NULL
13	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Left	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
with	NULL
a	NULL
30-fold	NULL
increase	NULL
throughout	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Thus	NULL
,	NULL
complex	NULL
formation	NULL
in	NULL
differentiating	NULL
progenitors	NULL
correlates	NULL
with	NULL
GATA-1	NULL
mRNA	NULL
detected	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

Concluding	NULL
Remarks	NULL
.	NULL

Our	NULL
findings	NULL
reveal	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
GATA-1	NULL
gene	NULL
in	NULL
normal	NULL
hematopoietic	NULL
progenitors	NULL
is	NULL
complex	NULL
and	NULL
involves	NULL
mechanisms	NULL
that	NULL
efficiently	NULL
activate	NULL
,	NULL
maintain	NULL
,	NULL
and	NULL
selectively	NULL
abrogate	NULL
expression	NULL
.	NULL

Initiation	NULL
of	NULL
GATA-1	NULL
expression	NULL
in	NULL
early	NULL
progenitor	NULL
cells	NULL
is	NULL
temporally	NULL
related	NULL
to	NULL
the	NULL
onset	NULL
of	NULL
cycling	NULL
activity	NULL
triggered	NULL
by	NULL
IL-3/GM-CSF	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
genetic	NULL
program	NULL
underlying	NULL
proliferation	NULL
of	NULL
stem/progenitor	NULL
cells	NULL
induces	NULL
the	NULL
switching	NULL
on	NULL
of	NULL
GATA-1	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

Maintenance	NULL
of	NULL
expression	NULL
in	NULL
developing	NULL
erythroid	NULL
cells	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
mediated	NULL
in	NULL
part	NULL
through	NULL
positive	NULL
autoregulation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
abrupt	NULL
down-regulation	NULL
of	NULL
GATA-1	NULL
expression	NULL
in	NULL
GM	NULL
development	NULL
implies	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
operating	NULL
in	NULL
late	NULL
GM	NULL
progenitors	NULL
to	NULL
curtail	NULL
autoregulation	NULL
or	NULL
actively	NULL
extinguish	NULL
expression	NULL
.	NULL

Though	NULL
GM	NULL
progenitors	NULL
appear	NULL
to	NULL
express	NULL
GATA-1	NULL
,	NULL
their	NULL
development	NULL
to	NULL
terminal	NULL
cells	NULL
proceeds	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
GATA-1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
initial	NULL
domain	NULL
of	NULL
GATA-1	NULL
expression	NULL
extends	NULL
beyond	NULL
that	NULL
of	NULL
the	NULL
mature	NULL
lineages	NULL
in	NULL
which	NULL
it	NULL
is	NULL
thought	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
transcriptional	NULL
regulator	NULL
(	NULL
30	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
widespread	NULL
distribution	NULL
of	NULL
the	NULL
myogenic	NULL
factor	NULL
MyoD	NULL
in	NULL
mesoderm	NULL
prior	NULL
to	NULL
sustained	NULL
expression	NULL
in	NULL
developing	NULL
muscle	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
are	NULL
compatible	NULL
with	NULL
a	NULL
two-step	NULL
model	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
GATA-1	NULL
in	NULL
early	NULL
hematopoiesis	NULL
,	NULL
which	NULL
involves	NULL
(	NULL
¢	NULL
)	NULL
initially	NULL
a	NULL
switch	NULL
on	NULL
,	NULL
linked	NULL
to	NULL
initiation	NULL
of	NULL
stem/	NULL
progenitor-cell	NULL
cycling	NULL
,	NULL
and	NULL
(	NULL
i	NULL
?	NULL
)	NULL

subsequently	NULL
,	NULL
increasing	NULL
expression	NULL
along	NULL
the	NULL
erythroid	NULL
differentiation	NULL
pathway	NULL
contrasted	NULL
with	NULL
abrupt	NULL
down-regulation	NULL
in	NULL
the	NULL
GM	NULL
lineage	NULL
at	NULL
a	NULL
relatively	NULL
advanced	NULL
stage	NULL
of	NULL
differentiation	NULL
.	NULL

If	NULL
cessation	NULL
of	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
6357	NULL
GATA-1	NULL
expression	NULL
is	NULL
obligatory	NULL
for	NULL
maturation	NULL
of	NULL
GM	NULL
progenitors	NULL
,	NULL
on/off	NULL
switches	NULL
of	NULL
lineage-restricted	NULL
transactivators	NULL
may	NULL
underlie	NULL
the	NULL
binary	NULL
fate	NULL
decisions	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
P.	NULL
Lansdorp	NULL
(	NULL
Terry	NULL
Fox	NULL
Laboratories	NULL
,	NULL
Vancouver	NULL
,	NULL
Canada	NULL
)	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
FTIC-labeled	NULL
8G12	NULL
anti-CD34	NULL
mAb	NULL
and	NULL
G.	NULL
Macioce	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Terapia	NULL
dei	NULL
Tumori	NULL
Program	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Rome	NULL
;	NULL
Progetto	NULL
Finalizzato	NULL
Ingegneria	NULL
Genetica	NULL
Grant	NULL
91.00062	NULL
(	NULL
C.P	NULL
.	NULL
)	NULL

,	NULL
Consiglio	NULL
Nazionale	NULL
delle	NULL
Ricerche	NULL
Rome	NULL
;	NULL
Grant	NULL
HL32262	NULL
(	NULL
S.H.0	NULL
.	NULL
)	NULL

,	NULL
Physician	NULL
Scientist	NULL
Award	NULL
HLO2347	NULL
(	NULL
L.1.Z	NULL
.	NULL
)	NULL

,	NULL
and	NULL
Grant	NULL
HL32259	NULL
(	NULL
S.H.0	NULL
.	NULL
)	NULL

,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
;	NULL
and	NULL
the	NULL
Charles	NULL
H.	NULL
Hood	NULL
Foundation	NULL
(	NULL
L.1.Z	NULL
.	NULL
)	NULL

.	NULL

S.H.0	NULL
.	NULL

is	NULL
an	NULL
Investigator	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

1	NULL
.	NULL

Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
339	NULL
,	NULL
27-30	NULL
.	NULL

2	NULL
.	NULL

Fauser	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Messner	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Blood	NULL
53	NULL
,	NULL
1023-1031	NULL
.	NULL

3	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
Kamen	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
1229-1237	NULL
.	NULL

4	NULL
.	NULL

Cross	NULL
,	NULL
M.	NULL
&	NULL
Dexter	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
271-280	NULL
.	NULL

5	NULL
.	NULL

Yang	NULL
,	NULL
Y.-C.	NULL
,	NULL
Ciarletta	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Temple	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Chung	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Kovacic	NULL
,	NULL
S.	NULL
,	NULL
Witek-Giannotti	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Leary	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Kriz	NULL
,	NULL
R.	NULL
,	NULL
Donahue	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
&	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
3-10	NULL
.	NULL

6	NULL
.	NULL

Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Witek	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Temple	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Wilkens	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Leary	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Luxenberg	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Jones	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Brown	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Kay	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Orr	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Showmaker	NULL
,	NULL
C.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Kaufman	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Kewick	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

&	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
810-815	NULL
.	NULL

7	NULL
.	NULL

Jacobs	NULL
,	NULL
K.	NULL
,	NULL
Shoemaker	NULL
,	NULL
C.	NULL
,	NULL
Rodersdorf	NULL
,	NULL
R.	NULL
,	NULL
Neill	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Kaufman	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Mufson	NULL
,	NULL
A.	NULL
,	NULL
Seehra	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Hewick	NULL
,	NULL
R.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Kawakita	NULL
,	NULL
M.	NULL
,	NULL
Shimizu	NULL
,	NULL
T.	NULL
&	NULL
Takaji	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
313	NULL
,	NULL
806-810	NULL
.	NULL

8	NULL
.	NULL

Souza	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Boone	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Gabrilove	NULL
,	NULL
J.	NULL
,	NULL
Lai	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Zsebo	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Murdock	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Chazin	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
Bruszewski	NULL
,	NULL
J.	NULL
,	NULL
Lu	NULL
,	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Barendt	NULL
,	NULL
J.	NULL
,	NULL
Platzer	NULL
,	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
M.	NULL
A.	NULL
S.	NULL
,	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
&	NULL
Welte	NULL
,	NULL
K.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
61-65	NULL
.	NULL

9	NULL
.	NULL

Kawasaki	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Arsdell	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Warren	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Coyne	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Schweickart	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Lee	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Wilson	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Boosman	NULL
,	NULL
A.	NULL
,	NULL
Stapley	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
&	NULL
Mark	NULL
,	NULL
D.	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
230	NULL
,	NULL
291-296	NULL
.	NULL

10	NULL
.	NULL

Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Mutter	NULL
,	NULL
G.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
444-449	NULL
.	NULL

11	NULL
.	NULL

Romeo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Prandini	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
&	NULL
Uzan	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
,	NULL
447-449	NULL
.	NULL

12	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
665-672	NULL
.	NULL

13	NULL
.	NULL

Pevny	NULL
,	NULL
L.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Robertson	NULL
,	NULL
E.	NULL
,	NULL
Klein	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
D	NULL
'	NULL
Agati	NULL
,	NULL
V.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Costantini	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
349	NULL
,	NULL
257-260	NULL
.	NULL

14	NULL
.	NULL

Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Strauss	NULL
,	NULL
E.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
919-931	NULL
.	NULL

15	NULL
.	NULL

Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
10638-10641	NULL
.	NULL

16	NULL
.	NULL

Khoury	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
378-381	NULL
.	NULL

17	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
&	NULL
Whitelaw	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
The	NULL
Regulation	NULL
of	NULL
Hemoglobin	NULL
Switching	NULL
,	NULL
eds	NULL
.	NULL

Stamatoyanno-poulos	NULL
,	NULL
G.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
Johns	NULL
Hopkins	NULL
Press	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

319-335	NULL
.	NULL

18	NULL
.	NULL

Crotta	NULL
,	NULL
S.	NULL
,	NULL
Nicolis	NULL
,	NULL
S.	NULL
,	NULL
Ronchi	NULL
,	NULL
A.	NULL
,	NULL
Ottolenghi	NULL
,	NULL
S.	NULL
,	NULL
Ruzzi	NULL
,	NULL
L.	NULL
,	NULL
Shimada	NULL
,	NULL
Y.	NULL
,	NULL
Migliaccio	NULL
,	NULL
A.	NULL
R.	NULL
&	NULL
Migliaccio	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6863-6869	NULL
.	NULL

19	NULL
.	NULL

Gabbianelli	NULL
,	NULL
M.	NULL
,	NULL
Sargiacomo	NULL
,	NULL
M.	NULL
,	NULL
Pelosi	NULL
,	NULL
E.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Isacchi	NULL
,	NULL
G.	NULL
&	NULL
Peschle	NULL
,	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1561-1564	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Valtieri	NULL
,	NULL
M.	NULL
,	NULL
Gabbianelli	NULL
,	NULL
M.	NULL
,	NULL
Pelosi	NULL
,	NULL
E.	NULL
,	NULL
Bassano	NULL
,	NULL
E.	NULL
,	NULL
Petti	NULL
,	NULL
S.	NULL
,	NULL
Russo	NULL
,	NULL
G.	NULL
,	NULL
Testa	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Peschle	NULL
,	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
460-470	NULL
.	NULL

21	NULL
.	NULL

Eliason	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Physiol	NULL
.	NULL

128	NULL
,	NULL
231-245	NULL
.	NULL

22	NULL
.	NULL

Suzuki	NULL
,	NULL
S.	NULL
&	NULL
Axelrad	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Cell	NULL
19	NULL
,	NULL
225-235	NULL
.	NULL

23	NULL
.	NULL

-	NULL
Valtieri	NULL
,	NULL
M.	NULL
,	NULL
Venturelli	NULL
,	NULL
D.	NULL
,	NULL
Carg	NULL
,	NULL
A.	NULL
,	NULL
Fossati	NULL
,	NULL
C.	NULL
,	NULL
Pelosi	NULL
,	NULL
E.	NULL
,	NULL
Labbaye	NULL
,	NULL
C.	NULL
,	NULL
Mattia	NULL
,	NULL
G.	NULL
,	NULL
Gewirtz	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Peschle	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1181-1190	NULL
.	NULL

24	NULL
.	NULL

-	NULL
Chirgwin	NULL
,	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Rutter	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5300	NULL
.	NULL

25	NULL
.	NULL

Trainor	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Evans	NULL
,	NULL
T.	NULL
,	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
&	NULL
Bogusky	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
343	NULL
,	NULL
92-96	NULL
.	NULL

26	NULL
.	NULL

Andrews	NULL
,	NULL
N.	NULL
C.	NULL
&	NULL
Faller	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
2499	NULL
.	NULL

27	NULL
.	NULL

Andrews	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Singer	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Bernstein	NULL
,	NULL
I.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169	NULL
,	NULL
1721-1731	NULL
.	NULL

28	NULL
.	NULL

-	NULL
Berenson	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Andrews	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Besinger	NULL
,	NULL
W.	NULL
I.	NULL
,	NULL
Kalamasw	NULL
,	NULL
D.	NULL
,	NULL
Knit-ter	NULL
,	NULL
G.	NULL
,	NULL
Buckner	NULL
,	NULL
C.	NULL
D.	NULL
&	NULL
Bernstein	NULL
,	NULL
I.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

81	NULL
,	NULL
951-961	NULL
.	NULL

29	NULL
.	NULL

Gianni	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Siena	NULL
,	NULL
S.	NULL
,	NULL
Bregni	NULL
,	NULL
M.	NULL
,	NULL
Torella	NULL
,	NULL
C.	NULL
,	NULL
Stern	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Pileri	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Bonadonna	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Lancet	NULL
it	NULL
,	NULL
580-584	NULL
.	NULL

30	NULL
.	NULL

Bensinger	NULL
,	NULL
W.	NULL
I.	NULL
,	NULL
Berenson	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Andrews	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Kalamoss	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Hill	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Bernstein	NULL
,	NULL
I.	NULL
D.	NULL
,	NULL
Lopez	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Buckner	NULL
,	NULL
C.	NULL
D.	NULL
&	NULL
Thomas	NULL
,	NULL
E.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Apheresis	NULL
5	NULL
,	NULL
74-76	NULL
.	NULL

31	NULL
.	NULL

Rupp	NULL
,	NULL
R.	NULL
A.	NULL
W.	NULL
&	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
927-937	NULL
.	NULL

